PortfoliosLab logoPortfoliosLab logo
ISIN
US52634L1089
CUSIP
52634L108
IPO Date
Oct 2, 2020

Highlights

Market Cap
$69.29M
Enterprise Value
$59.80M
EPS (TTM)
-$2.85
Total Revenue (TTM)
$58.44M
Gross Profit (TTM)
$27.12M
EBITDA (TTM)
-$17.15M
Year Range
$5.06 - $13.47
Target Price
$10.00
ROA (TTM)
-47.99%
ROE (TTM)
131.75%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


LENSAR, Inc.

Performance

LNSR Performance Chart

LENSAR, Inc. (LNSR) is down 50.6% since the beginning of the year. At $6 per share, LNSR is trading 57.4% below its 52-week high of $13. Investors who bought $1,000 worth of LNSR shares 5 years ago would now be looking at an investment worth $685.


Loading charts...

S&P 500 Index

Returns By Period

LENSAR, Inc. (LNSR) has returned -50.64% so far this year and -57.61% over the past 12 months.


LENSAR, Inc.

1D
0.00%
1M
3.24%
YTD
-50.64%
6M
-45.28%
1Y
-57.61%
3Y*
23.60%
5Y*
-7.29%
10Y*

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LNSR Monthly Returns History

Based on dividend-adjusted daily data since Oct 2, 2020, LNSR's average daily return is +0.06%, while the average monthly return is +0.98%. At this rate, an investment would double in approximately 5.9 years.

Historically, 42% of months were positive and 58% were negative. The best month was May 2024 with a return of +50.6%, while the worst month was Mar 2026 at -50.2%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 6 months.

On a daily basis, LNSR closed higher 47% of trading days. The best single day was Oct 5, 2020 with a return of +35.6%, while the worst single day was Mar 17, 2026 at -32.9%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20269.46%-5.97%-50.21%-12.25%10.90%-1.03%-50.64%
202524.16%17.12%8.62%-0.50%-3.70%-2.66%-2.13%-4.73%0.57%-0.40%-17.24%14.24%30.09%
20241.14%37.46%-30.39%-8.15%50.64%-4.26%10.89%-6.41%-1.93%24.02%32.57%18.73%154.70%
20231.62%2.73%-19.42%14.86%2.80%44.56%-22.82%3.66%-9.12%-30.42%15.81%40.96%18.58%
2022-0.25%-1.92%26.28%-1.49%-7.13%-3.84%-3.38%-14.31%2.97%-14.23%-30.46%-10.57%-50.58%
2021-3.59%29.33%-19.69%-4.82%19.68%4.72%-6.12%9.23%-13.85%-6.54%-4.62%-12.17%-17.38%

Benchmark Metrics

LENSAR, Inc. has an annualized alpha of 7.12%, beta of 0.50, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since October 05, 2020.

  • This stock participated in 105.13% of S&P 500 Index downside but only 25.00% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.50 may look defensive, but with R2 of 0.02 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
7.12%
Beta
0.50
0.02
Upside Capture
25.00%
Downside Capture
105.13%

Return for Risk

Risk / Return Rank

LNSR ranks 4 for risk / return — in the bottom 4% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


LNSR Risk / Return Rank: 44
Overall Rank
LNSR Sharpe Ratio Rank: 33
Sharpe Ratio Rank
LNSR Sortino Ratio Rank: 66
Sortino Ratio Rank
LNSR Omega Ratio Rank: 33
Omega Ratio Rank
LNSR Calmar Ratio Rank: 55
Calmar Ratio Rank
LNSR Martin Ratio Rank: 11
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for LENSAR, Inc. (LNSR) and compare them to S&P 500 Index.


LNSRBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-3.33

Sortino ratioReturn per unit of downside risk

-4.59

Omega ratioGain probability vs. loss probability

0.75

1.41

-0.66

Calmar ratioReturn relative to maximum drawdown

-0.93

2.93

-3.85

Martin ratioReturn relative to average drawdown

-1.99

13.52

-15.51

Dividends

Dividend History


LENSAR, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the LENSAR, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the LENSAR, Inc. was 83.52%, occurring on Nov 8, 2023. Recovery took 326 trading sessions.

The current LENSAR, Inc. drawdown is 65.98%.


Related event

Drawdown

Fall

Recovery

Underwater

2023 bear market2023
-83.52%Nov 2023
3y 1mo1y 3mo
4y 4moOct 2020 - Feb 2025
2026 bear market2026
-69.83%Apr 2026
1y 1mo
1y 2moMar 2025 - now
2025 selloff2025
-15.45%Mar 2025
4d2d
6dMar 2025 - Mar 2025
2025 selloff2025
-4.82%Mar 2025
0s4d
4dMar 2025 - Mar 2025
2025 selloff2025
-0.13%Mar 2025
0s1d
1dMar 2025 - Mar 2025

Drawdown Indicators


LNSRBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-83.52%

-56.78%

-26.74%

Max Drawdown (1Y)

Largest decline over 1 year

-62.32%

-9.10%

-53.22%

Max Drawdown (3Y)

Largest decline over 3 years

-69.83%

-18.90%

-50.93%

Max Drawdown (5Y)

Largest decline over 5 years

-77.36%

-25.43%

-51.93%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-65.98%

-0.74%

-65.24%

Average Drawdown

Average peak-to-trough decline

-48.80%

-10.72%

-38.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

29.04%

1.97%

+27.07%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of LENSAR, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how LENSAR, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for LNSR relative to other companies in the Medical Devices industry. Currently, LNSR has a P/S ratio of 1.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with LNSR

Add LENSAR, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with LNSR